🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label pilot study of the safety and tolerability of 7% hype...
Status
Completed
Location
University of North Carolina
Start Date
2007-09
Trial ID
NCT00546663
Treatments Being Tested
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
This is a multi-center 3-month study to determine the variation in ProAir D...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2022-03-01
Trial ID
NCT05241288
Treatments Being Tested
A randomized, 2-period crossover, single-center, open-label study for viral...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-05-04
Trial ID
NCT04681079
Treatments Being Tested
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
The purpose of this study is to test the body's response to several doses o...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2014-07
Trial ID
NCT02232087
Treatments Being Tested
The goal of this clinical trial is to compare responses to bronchodilator t...
Status
Unknown
Location
University of Virginia Sheridan Snyder Translational Fontaine Research Unit
Start Date
2024-02
Trial ID
NCT06271408
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440